Literature DB >> 21660655

Papain-like proteases of Staphylococcus aureus.

Tomasz Kantyka1, Lindsey N Shaw, Jan Potempa.   

Abstract

Staphylococcus aureus remains one of the major humanpathogens, causing a number of diverse infections. the growing antibiotic resistance, including vancomycin and methicilin-resistant strains raises the special interest in virulence mechanism of this pathogen. among a number of extracellular virulence factors, S. aureus secretes several proteases of three catalytic classes-metallo, serine and papain-like cysteine proteases. the expression of proteolytic enzymes is strictly controlled by global regulators of virulence factors expression agr and sar and proteases take a role in a phenotype change in postlogarithmic phase of growth. the staphylococcal proteases are secreted as proenzymes and undergo activation in a cascade manner. Staphopains, two cysteine, papain-like proteases of S. aureus are both approximately 20 kDa proteins that have almost identical three-dimensional structures, despite sharing limited primary sequence identity. although staphopain a displays activity similar to cathepsins, recognising hydrophobic residues at P2 position and large charged residues at P1, staphopain B differs significantly, showing significant preference towards β-branched residues at P2 and accepting only small, neutral residues at the P1 position. there is limited data available on the virulence potential of staphopains in in vivo models. However, in vitro experiments have demonstrated a very broad activity of these enzymes, including destruction of connective tissue, disturbance of clotting and kinin systems and direct interaction with host immune cells. Staphopain genes in various staphylococci species are regularly followed by a gene encoding an extremely specific inhibitor of the respective staphopain. This pattern is conserved across species and it is believed that inhibitors (staphostatins) protect the cytoplasm of the cell from premature activation of staphopains during protein folding. Notably, production and activity of staphopains is controlled on each level, from gene expression, through presence of specific inhibitors in cytoplasm, to the cascade-like activation in extracellular environment. Since these systems are highly conserved, this points to the importance of these proteases in the survival and/or pathogenicity of S. aureus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660655     DOI: 10.1007/978-1-4419-8414-2_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth.

Authors:  Stephan Zindel; Wendy E Kaman; Sabrina Fröls; Felicitas Pfeifer; Anna Peters; John P Hays; Hans-Lothar Fuchsbauer
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

Review 2.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

3.  Identification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus.

Authors:  Ronan K Carroll; Tiffany M Robison; Frances E Rivera; Jessica E Davenport; Ing-Marie Jonsson; Danuta Florczyk; Andrej Tarkowski; Jan Potempa; Joanna Koziel; Lindsey N Shaw
Journal:  Microbes Infect       Date:  2012-05-02       Impact factor: 2.700

4.  Staphylococcus aureus proteases degrade lung surfactant protein A potentially impairing innate immunity of the lung.

Authors:  Tomasz Kantyka; Krzysztof Pyrc; Milosz Gruca; Jan Smagur; Karolina Plaza; Krzysztof Guzik; Slawomir Zeglen; Marek Ochman; Jan Potempa
Journal:  J Innate Immun       Date:  2012-12-11       Impact factor: 7.349

5.  Staphopains modulate Staphylococcus aureus biofilm integrity.

Authors:  Joe M Mootz; Cheryl L Malone; Lindsey N Shaw; Alexander R Horswill
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

6.  Dibenzyl (benzo [d] thiazol-2-yl (hydroxy) methyl) phosphonate (DBTMP) showing anti-S. aureus and anti-biofilm properties by elevating activities of serine protease (SspA) and cysteine protease staphopain B (SspB).

Authors:  G Deepika; S Subbarayadu; Abhijit Chaudhary; P V G K Sarma
Journal:  Arch Microbiol       Date:  2022-06-16       Impact factor: 2.552

7.  The Staphylococcus aureus leucine aminopeptidase is localized to the bacterial cytosol and demonstrates a broad substrate range that extends beyond leucine.

Authors:  Ronan K Carroll; Florian Veillard; Danielle T Gagne; Jarrod M Lindenmuth; Marcin Poreba; Marcin Drag; Jan Potempa; Lindsey N Shaw
Journal:  Biol Chem       Date:  2013-06       Impact factor: 3.915

8.  Secretory Proteases of the Human Skin Microbiome.

Authors:  Wisely Chua; Si En Poh; Hao Li
Journal:  Infect Immun       Date:  2021-10-04       Impact factor: 3.609

9.  A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes.

Authors:  Paul D Fey; Jennifer L Endres; Vijaya Kumar Yajjala; Todd J Widhelm; Robert J Boissy; Jeffrey L Bose; Kenneth W Bayles
Journal:  MBio       Date:  2013-02-12       Impact factor: 7.867

10.  CcpA regulates arginine biosynthesis in Staphylococcus aureus through repression of proline catabolism.

Authors:  Austin S Nuxoll; Steven M Halouska; Marat R Sadykov; Mark L Hanke; Kenneth W Bayles; Tammy Kielian; Robert Powers; Paul D Fey
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.